New Hope for Lung Cancer Patients

New Hope for Lung Cancer Patients

The University of Colorado Cancer Center’s run in advancing targeted lung cancer therapies continues, this time with an experimental drug called brigatinib. The center established itself as a central player in ALK-positive non-small cell lung cancer in the run-up to...